These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 25724578)

  • 21. Progenitor marker CD133 mRNA is elevated in peripheral blood of cancer patients with bone metastases.
    Mehra N; Penning M; Maas J; Beerepoot LV; van Daal N; van Gils CH; Giles RH; Voest EE
    Clin Cancer Res; 2006 Aug; 12(16):4859-66. PubMed ID: 16914572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High levels of circulating CD34 cells, dacrocytes, clonal hematopoiesis, and JAK2 mutation differentiate myelofibrosis with myeloid metaplasia from secondary myelofibrosis associated with pulmonary hypertension.
    Popat U; Frost A; Liu E; Guan Y; Durette A; Reddy V; Prchal JT
    Blood; 2006 May; 107(9):3486-8. PubMed ID: 16418333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD133(+) cells isolated from various sources and their role in future clinical perspectives.
    Meregalli M; Farini A; Belicchi M; Torrente Y
    Expert Opin Biol Ther; 2010 Nov; 10(11):1521-8. PubMed ID: 20932225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Expression of AC133 vs. CD34 in acute childhood leukemias].
    Ebener U; Brinkmann A; Zotova V; Niegemann E; Wehner S
    Klin Padiatr; 2000; 212(3):90-8. PubMed ID: 10916777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Despite inhibition of hematopoietic progenitor cell growth in vitro, the tyrosine kinase inhibitor imatinib does not impair engraftment of human CD133+ cells into NOD/SCIDbeta2mNull mice.
    Pirson L; Baron F; Meuris N; Giet O; Castermans E; Greimers R; Di Stefano I; Gothot A; Beguin Y
    Stem Cells; 2006 Jul; 24(7):1814-21. PubMed ID: 16614006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathogenesis of myelofibrosis with myeloid metaplasia.
    Tefferi A
    J Clin Oncol; 2005 Nov; 23(33):8520-30. PubMed ID: 16293880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Megakaryocytic morphology and clinical parameters in essential thrombocythemia, polycythemia vera, and primary myelofibrosis with and without JAK2 V617F.
    Vytrva N; Stacher E; Regitnig P; Zinke-Cerwenka W; Hojas S; Hubmann E; Porwit A; Bjorkholm M; Hoefler G; Beham-Schmid C
    Arch Pathol Lab Med; 2014 Sep; 138(9):1203-9. PubMed ID: 25171702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human primary bone sarcomas contain CD133+ cancer stem cells displaying high tumorigenicity in vivo.
    Tirino V; Desiderio V; Paino F; De Rosa A; Papaccio F; Fazioli F; Pirozzi G; Papaccio G
    FASEB J; 2011 Jun; 25(6):2022-30. PubMed ID: 21385990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].
    Rajnai H; Bödör C; Reiniger L; Timár B; Csernus B; Szepesi A; Csomor J; Matolcsy A
    Orv Hetil; 2006 Nov; 147(45):2175-9. PubMed ID: 17402211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary myelofibrosis: 2013 update on diagnosis, risk-stratification, and management.
    Tefferi A
    Am J Hematol; 2013 Feb; 88(2):141-50. PubMed ID: 23349007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Ex vivo expansion of megakaryocyte progenitor cells for CD133(+) cells derived from human umbilical cord blood].
    Wang L; Chen DX; Fang N; Liu ZL; Zhang T; Wan WH; Qi Y; Liu JW
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):645-9. PubMed ID: 18549646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Revision of the human hematopoietic tree: granulocyte subtypes derive from distinct hematopoietic lineages.
    Görgens A; Radtke S; Möllmann M; Cross M; Dürig J; Horn PA; Giebel B
    Cell Rep; 2013 May; 3(5):1539-52. PubMed ID: 23707063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different involvement of the megakaryocytic lineage by the JAK2 V617F mutation in Polycythemia vera, essential thrombocythemia and chronic idiopathic myelofibrosis.
    Hussein K; Brakensiek K; Buesche G; Buhr T; Wiese B; Kreipe H; Bock O
    Ann Hematol; 2007 Apr; 86(4):245-53. PubMed ID: 17262192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single-Cell Analyses Reveal Megakaryocyte-Biased Hematopoiesis in Myelofibrosis and Identify Mutant Clone-Specific Targets.
    Psaila B; Wang G; Rodriguez-Meira A; Li R; Heuston EF; Murphy L; Yee D; Hitchcock IS; Sousos N; O'Sullivan J; Anderson S; Senis YA; Weinberg OK; Calicchio ML; ; Iskander D; Royston D; Milojkovic D; Roberts I; Bodine DM; Thongjuea S; Mead AJ
    Mol Cell; 2020 May; 78(3):477-492.e8. PubMed ID: 32386542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of JAK2 V617F mutation, spontaneous erythropoiesis and megakaryocytopoiesis, hypersensitive platelets, activated leukocytes, and endothelial cells in the etiology of thrombotic manifestations in polycythemia vera and essential thrombocythemia.
    Bellucci S; Michiels JJ
    Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):381-98. PubMed ID: 16810614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity.
    Yin S; Li J; Hu C; Chen X; Yao M; Yan M; Jiang G; Ge C; Xie H; Wan D; Yang S; Zheng S; Gu J
    Int J Cancer; 2007 Apr; 120(7):1444-50. PubMed ID: 17205516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary myelofibrosis marrow-derived CD14+/CD34- monocytes induce myelofibrosis-like phenotype in immunodeficient mice and give rise to megakaryocytes.
    Manshouri T; Verstovsek S; Harris DM; Veletic I; Zhang X; Post SM; Bueso-Ramos CE; Estrov Z
    PLoS One; 2019; 14(9):e0222912. PubMed ID: 31569199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary myelofibrosis and the myeloproliferative neoplasms: the role of individual variation.
    Stein BL; Moliterno AR
    JAMA; 2010 Jun; 303(24):2513-8. PubMed ID: 20571018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Haematopoietic repopulating activity in human cord blood CD133+ quiescent cells.
    Boxall SA; Cook GP; Pearce D; Bonnet D; El-Sherbiny YM; Blundell MP; Howe SJ; Leek JP; Markham AF; de Wynter EA
    Bone Marrow Transplant; 2009 Apr; 43(8):627-35. PubMed ID: 18997827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human cord blood CD133+ cells exacerbate ischemic acute kidney injury in mice.
    Burger D; Gutsol A; Carter A; Allan DS; Touyz RM; Burns KD
    Nephrol Dial Transplant; 2012 Oct; 27(10):3781-9. PubMed ID: 22561581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.